Health Leaders Discuss Longevity Research and the 150-Year Age Limit
Experts gathering at the TIME100 Health Leadership Forum in New York stated that children born today could live up to 150 years thanks to advancements in medicine and technology.
Speaking at the TIME100 Health Leadership Forum in New York, Harvard professor David Sinclair and other health leaders stated that thanks to next-generation medical technologies, children born today could reach the 22nd century and live a lifespan of 150 years.
Longevity Discussions at the Forum
Groundbreaking research aimed at extending human lifespan in the future was discussed at the TIME100 Health Leadership Forum held in New York City.
The Generation to Reach Age 150
David Sinclair, a professor at Harvard Medical School, stated that the first person in the world to live up to 150 years old is already living among us.
Sinclair noted that children born today will be able to see the 22nd century and access unimaginable technologies akin to five years of rapid development in artificial intelligence and healthcare.
Data Gap on Sex Differences in Medical Research
Jennifer Garrison, a neuroscientist specializing in women's health biotechnology, drew attention to the lack of data and systemic biases regarding female physiology.
Garrison stated that understanding biological differences between sexes, particularly through ovaries, is critical for developing better medicines for everyone.
Criticism of the Traditional Healthcare System
Jack Jia, the founder and CEO of Musely, explained that after searching for a cure for his wife's skin condition, he shifted his company toward proactive health and longevity.
Jia criticized the traditional healthcare system, stating that it is primarily designed for severely ill patients rather than preventive wellness.
Reliability Issues in the Market
Jennifer Garrison warned that in the face of recently increasing longevity tests, many products on the market lack evidence or lean toward pseudoscience. Meanwhile, David Sinclair expressed concern over people turning to unapproved drugs or peptide injections, while also touching upon the easing of regulations.